EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.4.3.13 | protein-lysine 6-oxidase |
pancreatic cancer cell line |
- |
765826 |
2.1.1.348 | mRNA m6A methyltransferase |
pancreatic cancer cell line |
- |
757908 |
2.4.1.145 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
pancreatic cancer cell line |
Panc-1, PCI6, MIA PaCa-2, and BxPC3. Down-regulation of GnT-IVa in pancreatic cancer cells is due to an epigenetic abnormality in the gene. When pancreatic cancer cells are treated with 5-aza-C or butyrate, the expression of GnT-IVa is dramatically increased |
671742 |
2.4.1.145 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
pancreatic cancer cell line |
Panc-1, PCI6, MIA PaCa-2, and BxPC3. Expression of GnT-IVb is increased in pancreatic cancer, compared to normal pancreatic tissues |
671742 |
2.5.1.1 | dimethylallyltranstransferase |
pancreatic cancer cell line |
- |
759609 |
2.5.1.10 | (2E,6E)-farnesyl diphosphate synthase |
pancreatic cancer cell line |
- |
759609 |
2.5.1.29 | geranylgeranyl diphosphate synthase |
pancreatic cancer cell line |
- |
759609 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
- |
672917 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
4964LM cell |
672917 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
4964PDA cell |
672917 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
5143LM cell |
672917 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
5143PDA cell |
672917 |
2.7.10.1 | receptor protein-tyrosine kinase |
pancreatic cancer cell line |
HS7665 cell |
672875 |
2.7.12.2 | mitogen-activated protein kinase kinase |
pancreatic cancer cell line |
- |
491878 |
3.4.21.68 | t-Plasminogen activator |
pancreatic cancer cell line |
PANC1 |
683505 |
3.4.21.B39 | stratum corneum tryptic enzyme |
pancreatic cancer cell line |
high expression |
670977 |
3.4.24.86 | ADAM 17 endopeptidase |
pancreatic cancer cell line |
ADAM17/TACE mRNA is expressed in 10 of 10 PDAC tissues. ADAM17/TACE mRNA expression is down-regulated in pancreatic cancer cells arrested in G2 -M phase. Critical involvement of ADAM17/TACE in the invasion behavior of pancreatic cancer cells |
668163 |
6.3.4.5 | argininosuccinate synthase |
pancreatic cancer cell line |
pancreatic cancer cell line, low ASS expression level |
692659 |
6.5.1.1 | DNA ligase (ATP) |
pancreatic cancer cell line |
MiaPaCa cell line |
650859 |